by Syneos Health_1 | 19 Aug, 2019 | Biological Products, Biosamples, Genetic Research, Human Tissue Research
Source: https://lifescienceslawblog.fieldfisher.com/2019/china-s-new-regulations-on-the-management-of-human-genetic-resources China is a multi-ethnic country with a large population offering unique human genetic resources. International cooperation in the field of...
by Syneos Health_1 | 30 May, 2019 | CHCUK News & Articles, Consultation, Real Word Evidence, Real World Research Design, Regulatory Grade RWE
May 2019 – the Center for Drug Evaluation (China) has released a draft document for public review on “Key Considerations in Using Real-World Evidence to Support Drug Development” Background and Purpose Randomized Controlled Trials (RCTs) are...
by chuck_ltd | 15 Jan, 2016 | CHCUK News & Articles, News
We have analyzed drug policies with regard to drug pricing and the centralized procurement of drugs in the previous Key 2015 Healthcare and Pharmaceutical Policies: Pharmaceuticals. This article will sort out China’s key regulations and policies in 2015 related to...
